Charles S. Matthews

1.3k citations

20 papers · 1.1k indexed · h-index 14

Co-authors: Malcolm F. G. Stevens Andrew D. Westwell Tracey D. Bradshaw Geoffrey Wells Cédric Lion Hachemi Kadri Erica L. Stone Rana Bazzi
Topics: Synthesis and Biological Evaluation (8 papers)Synthesis and Characterization of Heterocyclic Compounds (6 papers)Synthesis and biological activity (6 papers)
Cited by: Organic Chemistry Toxicology Geriatrics and Gerontology
Journals: Cancer Research Chemical Communications Clinical Cancer Research
Partner nations: United Kingdom United States Malaysia

In The Last Decade

Charles S. Matthews

20 papers receiving 1.1k citations

Peers

Countries citing papers authored by Charles S. Matthews

Since Specialization

Citations

This map shows the geographic impact of Charles S. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Matthews more than expected).

Fields of papers citing papers by Charles S. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Matthews. The network helps show where Charles S. Matthews may publish in the future.

Co-authorship network of co-authors of Charles S. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Matthews. A scholar is included among the top collaborators of Charles S. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Matthews. Charles S. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antitumor imidazo[5,1-d]-1,2,3,5-tetrazines: compounds modified at the 3-position overcome resistance in human glioblastoma cell lines 2016 ·MedChemComm ·(unknown),Jihong Zhang,Marc Hummersone,Charles S. Matthews,Mark Frigerio,Tracey D. Bradshaw,Malcolm F. G. Stevens	16
2	N3-Substituted Temozolomide Analogs Overcome Methylguanine-DNA Methyltransferase and Mismatch Repair Precipitating Apoptotic and Autophagic Cancer Cell Death 2014 ·Oncology ·Jihong Zhang,Marc Hummersone,Charles S. Matthews,Malcolm F. G. Stevens,Tracey D. Bradshaw	24
3	Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions 2010 ·Organic & Biomolecular Chemistry ·Andrew J. McCarroll,Charles S. Matthews,Geoffrey Wells,Tracey D. Bradshaw,Malcolm F. G. Stevens	10
4	Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-one Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648) 2008 ·Journal of Medicinal Chemistry ·Stefania Aiello,Geoffrey Wells,Erica L. Stone,Hachemi Kadri,Rana Bazzi,David Bell,Malcolm F. G. Stevens,Charles S. Matthews,Tracey D. Bradshaw,Andrew D. Westwell	297
5	Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles 2008 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Hachemi Kadri,Charles S. Matthews,Tracey D. Bradshaw,Malcolm F. G. Stevens,Andrew D. Westwell	21
6	Induction of G1 arrest and apoptosis by new benzylidene derivatives of andrographolide in breast and colon cancer cells 2007 ·Clinical Cancer Research ·Srinivasa Rao Jada,Charles S. Matthews,(unknown),Ahmad Sazali Hamzah,Nordin H. Lajis,Malcolm F. G. Stevens,Johnson Stanslas	1
7	Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines 2007 ·Breast Cancer Research and Treatment ·Tracey D. Bradshaw,Erica L. Stone,Valentina Trapani,Chee‐Onn Leong,Charles S. Matthews,Robert te Poele,Malcolm F. G. Stevens	30
8	Quinols As Novel Therapeutic Agents. 7. Synthesis of Antitumor 4-[1-(Arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira Reactions 2007 ·Journal of Medicinal Chemistry ·Andrew J. McCarroll,Tracey D. Bradshaw,Andrew D. Westwell,Charles S. Matthews,Malcolm F. G. Stevens	34
9	Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones (‘quinols’) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Cédric Lion,Charles S. Matthews,Geoffrey Wells,Tracey D. Bradshaw,Malcolm F. G. Stevens,Andrew D. Westwell	106
10	Antitumor quinols: Role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets 2006 ·Biochemical and Biophysical Research Communications ·Eng‐Hui Chew,Charles S. Matthews,Jihong Zhang,Andrew J. McCarroll,Thilo Hagen,Malcolm F. G. Stevens,Andrew D. Westwell,Tracey D. Bradshaw	17
11	Structural Studies on Bioactive Compounds. 40. Synthesis and Biological Properties of Fluoro-, Methoxyl-, and Amino-Substituted 3-Phenyl-4H-1-benzopyran-4-ones and a Comparison of Their Antitumor Activities with the Activities of Related 2-Phenylbenzothiazoles 2006 ·Journal of Medicinal Chemistry ·(unknown),Andrew D. Westwell,Charles S. Matthews,Tracey D. Bradshaw,Malcolm F. G. Stevens	71
12	Novel reaction products from the hypervalent iodine oxidation of hydroxylated stilbenes and isoflavones 2005 ·Organic & Biomolecular Chemistry ·Cédric Lion,(unknown),Carl H. Schwalbe,Charles S. Matthews,Malcolm F. G. Stevens,Andrew D. Westwell	10
13	Synthesis, Antitumor Evaluation, and Apoptosis-Inducing Activity of Hydroxylated (E)-Stilbenes 2005 ·Journal of Medicinal Chemistry ·Cédric Lion,Charles S. Matthews,Malcolm F. G. Stevens,Andrew D. Westwell	61
14	Elucidation of Thioredoxin as a Molecular Target for Antitumor Quinols 2005 ·Cancer Research ·Tracey D. Bradshaw,Charles S. Matthews,(unknown),Eng‐Hui Chew,Manish A. Shah,Kevin Bailey,Anne Monks,Erik Harris,Andrew D. Westwell,Geoffrey Wells,Charles A. Laughton,Malcolm F. G. Stevens	78
15	Structural Studies on Bioactive Compounds. 39. Biological Consequences of the Structural Modification of DHFR-Inhibitory 2,4-Diamino-6-(4-substituted benzylamino-3-nitrophenyl)-6-ethylpyrimidines (‘benzoprims') 2004 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Charles S. Matthews,Malcolm F. G. Stevens	7
16	Antitumor Benzothiazoles. Part 20. 3′‐Cyano and 3′‐Alkynyl‐Substituted 2‐(4′‐Aminophenyl)benzothiazoles as New Potent and Selective Analogues. 2003 ·ChemInform ·Ian Hutchinson,Tracey D. Bradshaw,Charles S. Matthews,Malcolm F. G. Stevens,Andrew D. Westwell	2
17	Antitumour benzothiazoles. Part 20: 3′-Cyano and 3′-Alkynyl-Substituted 2-(4′-Aminophenyl)benzothiazoles as new potent and selective analogues 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ian Hutchinson,Tracey D. Bradshaw,Charles S. Matthews,Malcolm F. G. Stevens,Andrew D. Westwell	115
18	Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agents 2002 ·Chemical Communications ·(unknown),(unknown),Arnaud Tiberghien,(unknown),Charles S. Matthews,Philip W. Howard,David E. Thurston	34
19	Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design. 2002 ·PubMed ·(unknown),Charles S. Matthews,Roger J. Griffin,Malcolm F. G. Stevens	1
20	Screening for Depression: Single Question versus GDS 1994 ·Journal of the American Geriatrics Society ·(unknown),Theresa J. K. Drinka,(unknown),Gail Gunter‐Hunt,Charles S. Matthews,(unknown),Molly Carnes	174

About Charles S. Matthews

Charles S. Matthews is a scholar working on Neuropsychology and Physiological Psychology, Toxicology and Organic Chemistry, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (8 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Synthesis and biological activity (6 papers). The work is most often cited by research in Organic Chemistry (713 citations), Toxicology (47 citations) and Geriatrics and Gerontology (48 citations). Charles S. Matthews has collaborated with scholars based in United Kingdom, United States and Malaysia. Frequent co-authors include Malcolm F. G. Stevens, Andrew D. Westwell, Tracey D. Bradshaw, Geoffrey Wells, Cédric Lion, Hachemi Kadri, Erica L. Stone, Rana Bazzi, David Bell and Stefania Aiello. Their work appears in journals such as Cancer Research, Chemical Communications and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact